ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC39.0

C39.0

Billable

Malignant neoplasm of upper respiratory tract, part unspecified

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C39.0 is a billable code used to indicate a diagnosis of malignant neoplasm of upper respiratory tract, part unspecified.

Key Diagnostic Point:

C39.0 refers to malignant neoplasms located in the upper respiratory tract, where the specific part affected is not clearly defined. This category encompasses a variety of cancers that may arise in the larynx, pharynx, or other upper respiratory structures. These malignancies can present with symptoms such as persistent cough, difficulty swallowing, hoarseness, or unexplained weight loss. The diagnosis often requires imaging studies, biopsies, and thorough clinical evaluation. Surgical intervention may be necessary, depending on the tumor's size, location, and stage. Surgical options can include resection of the tumor, laryngectomy, or tracheostomy, particularly if there is mediastinal involvement or airway obstruction. The prognosis varies significantly based on the tumor type, stage at diagnosis, and response to treatment. Multidisciplinary management involving oncologists, surgeons, and radiologists is crucial for optimal outcomes.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in tumor location and type within the upper respiratory tract
  • Need for precise documentation of tumor staging and characteristics
  • Potential for concurrent respiratory conditions complicating diagnosis
  • Variability in treatment approaches based on tumor characteristics

Audit Risk Factors

  • Inadequate documentation of tumor characteristics
  • Failure to specify the exact site of malignancy
  • Lack of clarity on treatment plans and outcomes
  • Inconsistent coding of related conditions

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed pathology reports, imaging studies, and treatment plans must be documented.

Common Clinical Scenarios

Diagnosis and management of upper respiratory tract cancers, including staging and treatment planning.

Billing Considerations

Ensure accurate staging and characterization of the tumor to support coding.

Otolaryngology

Documentation Requirements

Surgical notes, pre-operative assessments, and post-operative follow-ups are essential.

Common Clinical Scenarios

Surgical interventions for upper respiratory tract malignancies, including laryngectomy and tracheostomy.

Billing Considerations

Document the specific anatomical site and extent of the disease for accurate coding.

Coding Guidelines

Inclusion Criteria

Use C39.0 When
  • Follow the official ICD
  • CM coding guidelines, ensuring that the code is used only when the specific site of the malignancy is not documented
  • Include relevant clinical information to support the diagnosis

Exclusion Criteria

Do NOT use C39.0 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

31540CPT Code

Laryngoscopy, direct, with or without biopsy

Clinical Scenario

Used for diagnostic evaluation of suspected malignancy in the upper respiratory tract.

Documentation Requirements

Document indications for the procedure and findings.

Specialty Considerations

Otolaryngologists should ensure thorough documentation of findings and any biopsies taken.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of malignancies, improving the granularity of data collection and enhancing the ability to track treatment outcomes. C39.0 serves as a catch-all for unspecified upper respiratory tract malignancies, necessitating careful documentation to avoid misclassification.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of malignancies, improving the granularity of data collection and enhancing the ability to track treatment outcomes. C39.0 serves as a catch-all for unspecified upper respiratory tract malignancies, necessitating careful documentation to avoid misclassification.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of malignancies, improving the granularity of data collection and enhancing the ability to track treatment outcomes. C39.0 serves as a catch-all for unspecified upper respiratory tract malignancies, necessitating careful documentation to avoid misclassification.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

When should C39.0 be used?

C39.0 should be used when a malignant neoplasm is diagnosed in the upper respiratory tract, but the specific site is not documented. Ensure that all clinical information supports the diagnosis.